Vaginal microbiota and its role in HIV transmission and infection

FEMS Microbiology Reviews

Volumn 37, Issue 5, 2013, Pages 762-792

  Petrova, Mariya I ^a,b   van den Broek, Marianne ^a,b   Balzarini, Jan ^c   Vanderleyden, Jos ^a   Lebeer, Sarah ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Epithelial barrier; Immunomodulation; Microbicide; Pathogen exclusion; Probiotics; Urogenital tract

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; ESTROGEN; MICROBICIDE; PROBIOTIC AGENT;

ACTINOMYCES; ATOPOBIUM; BACTERIAL COLONIZATION; BACTEROIDES; CANDIDA GLABRATA; CANDIDA KRUSEI; CLOSTRIDIALES; COLUMNAR EPITHELIUM; CORYNEBACTERIUM; DENDRITIC CELL; DISEASE COURSE; EGGERTHELLA; FEMALE GENITAL SYSTEM; GARDNERELLA; GARDNERELLA VAGINALIS; GASTROINTESTINAL TRACT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IN VITRO STUDY; INFECTION PREVENTION; INFECTION RESISTANCE; INFECTION RISK; INTESTINE LYMPHATIC TISSUE; LACTIC ACID BACTERIUM; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS AMYLOVORUS; LACTOBACILLUS CRISPATUS; LACTOBACILLUS FERMENTUM; LACTOBACILLUS GASSERI; LACTOBACILLUS JENSENII; LACTOBACILLUS JOHNSONII; LACTOBACILLUS PENTOSUS; LACTOBACILLUS PLANTARUM; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; LEPTOTRICHIA; MEGASPHAERA; MOBILUNCUS; MYCOPLASMA HOMINIS; NEUTROPHIL; NONHUMAN; PARVIMONAS; PORPHYROMONAS; PREVOTELLA; PREVOTELLA BIVIA; PROPIONIBACTERIACEAE; PROPIONIBACTERIUM; REVIEW; SEXUAL TRANSMISSION; SEXUALLY TRANSMITTED DISEASE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; T LYMPHOCYTE; UROGENITAL SYSTEM; VAGINA FLORA; VAGINITIS; VEILLONELLA; VIRUS REPLICATION; VIRUS TRANSMISSION;

EPITHELIAL BARRIER; IMMUNOMODULATION; MICROBICIDE; PATHOGEN EXCLUSION; PROBIOTICS; UROGENITAL TRACT;

ANIMALS; FEMALE; HIV INFECTIONS; HOST-PATHOGEN INTERACTIONS; HUMANS; MALE; MICROBIOTA; UROGENITAL SYSTEM; VAGINA;

BACTERIA (MICROORGANISMS); LACTOBACILLUS;

EID: 84881239811     PISSN: 01686445     EISSN: 15746976     Source Type: Journal    
DOI: 10.1111/1574-6976.12029     Document Type: Review

References (224)

1. Aagaard K, Riehle K, Ma J et al. (2012) A metagenomic approach to characterization of the vaginal microbiome signature in pregnancy. PLoS ONE 7: e36466.
2. Akinsiku OT, Bansal A, Sabbaj S, Heath SL & Goepfert PA (2011) Interleukin-2 production by polyfunctional HIV-1-specific CD8 T cells is associated with enhanced viral suppression. J Acquir Immune Defic Syndr 58: 132-140.
3. Alexopoulou L, Holt AC, Medzhitov R & Flavell RA (2001) Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413: 732-738.
4. Al-Harthi L, Roebuck KA, Olinger GG, Landay A, Sha BE, Hashemi FB & Spear GT (1999) Bacterial vaginosis-associated microflora isolated from the female genital tract activates HIV-1 expression. J Acquir Immune Defic Syndr 21: 194-202.
5. Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D & Holmes KK (1983) Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 74: 14-22.
6. Andersch-Bjorkman Y, Thomsson KA, Holmen Larsson JM, Ekerhovd E & Hansson GC (2007) Large scale identification of proteins, mucins, and their O-glycosylation in the endocervical mucus during the menstrual cycle. Mol Cell Proteomics 6: 708-716.
7. Antonio MA, Hawes SE & Hillier SL (1999) The identification of vaginal Lactobacillus species and the demographic and microbiologic characteristics of women colonized by these species. J Infect Dis 180: 1950-1956.
8. Anukam KC, Osazuwa EO, Ahonkhai I & Reid G (2006) Lactobacillus vaginal microbiota of women attending a reproductive health care service in Benin city, Nigeria. Sex Transm Dis 33: 59-62.
9. Anukam KC, Osazuwa EO, Osadolor HB, Bruce AW & Reid G (2008) Yogurt containing probiotic Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 helps resolve moderate diarrhea and increases CD4 count in HIV/AIDS patients. J Clin Gastroenterol 42: 239-243.
10. Anukam KC, Macklaim JM, Gloor GB, Reid G, Boekhorst J, Renckens B, van Hijum SA & Siezen RJ (2013) Genome sequence of Lactobacillus pentosus KCA1: vaginal isolate from a healthy premenopausal woman. PLoS ONE 8: e59239.
11. Arumugam M, Raes J, Pelletier E et al. (2011) Enterotypes of the human gut microbiome. Nature 473: 174-180.
12. Balkus JE, Mitchell C, Agnew K, Liu C, Fiedler T, Cohn SE, Luque A, Coombs R, Fredricks DN & Hitti J (2012) Detection of hydrogen peroxide-producing Lactobacillus species in the vagina: a comparison of culture and quantitative PCR among HIV-1 seropositive women. BMC Infect Dis 12: 188-193.
13. Balzarini J (2007) Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy. Nat Rev Microbiol 5: 583-597.
14. Balzarini J, Van LK, Peumans WJ, Van Damme EJ, Bolmstedt A, Gago F & Schols D (2006) Mutational pathways, resistance profile, and side effects of cyanovirin relative to human immunodeficiency virus type 1 strains with N-glycan deletions in their gp120 envelopes. J Virol 80: 8411-8421.
15. Bloomfield SE & Lopez C (1980) Herpes infections in the immunosuppressed host. Ophthalmology 87: 1226-1235.
16. Boskey ER, Telsch KM, Whaley KJ, Moench TR & Cone RA (1999) Acid production by vaginal flora in vitro is consistent with the rate and extent of vaginal acidification. Infect Immun 67: 5170-5175.
17. Botos I & Wlodawer A (2005) Proteins that bind high-mannose sugars of the HIV envelope. Prog Biophys Mol Biol 88: 233-282.
18. Braat H, van den BJ, van TE, Hommes D, Peppelenbosch M & van DS (2004) Lactobacillus rhamnosus induces peripheral hyporesponsiveness in stimulated CD4+ T cells via modulation of dendritic cell function. Am J Clin Nutr 80: 1618-1625.
19. Brenchley JM & Douek DC (2008) HIV infection and the gastrointestinal immune system. Mucosal Immunol 1: 23-30.
20. Brenchley JM, Price DA, Schacker TW et al. (2006) Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 12: 1365-1371.
21. Brenchley JM, Paiardini M, Knox KS et al. (2008) Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood 112: 2826-2835.
22. Burton JP & Reid G (2002) Evaluation of the bacterial vaginal flora of 20 postmenopausal women by direct (Nugent score) and molecular (polymerase chain reaction and denaturing gradient gel electrophoresis) techniques. J Infect Dis 186: 1770-1780.
23. Cameron PU, Freudenthal PS, Barker JM, Gezelter S, Inaba K & Steinman RM (1992) Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4+ T cells. Science 257: 383-387.
24. Chancey CJ, Khanna KV, Seegers JF, Zhang GW, Hildreth J, Langan A & Markham RB (2006) Lactobacilli-expressed single-chain variable fragment (scFv) specific for intercellular adhesion molecule 1 (ICAM-1) blocks cell-associated HIV-1 transmission across a cervical epithelial monolayer. J Immunol 176: 5627-5636.
25. Chang TL, Chang CH, Simpson DA et al. (2003) Inhibition of HIV infectivity by a natural human isolate of Lactobacillus jensenii engineered to express functional two-domain CD4. P Natl Acad Sci USA 100: 11672-11677.
26. Chege D, Sheth PM, Kain T et al. (2011) Sigmoid Th17 populations, the HIV latent reservoir, and microbial translocation in men on long-term antiretroviral therapy. AIDS 25: 741-749.
27. Clerici M & Shearer GM (1993) A TH1->TH2 switch is a critical step in the etiology of HIV infection. Immunol Today 14: 107-111.
28. Cohen CR, Duerr A, Pruithithada N, Rugpao S, Hillier S, Garcia P & Nelson K (1995) Bacterial vaginosis and HIV seroprevalence among female commercial sex workers in Chiang Mai, Thailand. AIDS 9: 1093-1097.
29. Collins KB, Patterson BK, Naus GJ, Landers DV & Gupta P (2000) Development of an in vitro organ culture model to study transmission of HIV-1 in the female genital tract. Nat Med 6: 475-479.
30. Conti C, Malacrino C & Mastromarino P (2009) Inhibition of herpes simplex virus type 2 by vaginal lactobacilli. J Physiol Pharmacol 60: 19-26.
31. Corey L (2007a) Herpes simplex virus type 2 and HIV-1: the dialogue between the 2 organisms continues. J Infect Dis 195: 1242-1244.
32. Corey L (2007b) Synergistic copathogens-HIV-1 and HSV-2. N Engl J Med 356: 854-856.
33. Cotter PD, Ross RP & Hill C (2013) Bacteriocins - a viable alternative to antibiotics? Nat Rev Microbiol 11: 95-105.
34. Cotter PD, Hill C & Ross RP (2005) Bacteriocins: developing innate immunity for food. Nat Rev Microbiol 3: 777-788.
35. Cribby S, Taylor M & Reid G (2008) Vaginal microbiota and the use of probiotics. Interdiscip Perspect Infect Dis 29: 256490.
36. Cummins JE Jr, Guarner J, Flowers L, Guenthner PC, Bartlett J, Morken T, Grohskopf LA, Paxton L & Dezzutti CS (2007) Preclinical testing of candidate topical microbicides for anti-human immunodeficiency virus type 1 activity and tissue toxicity in a human cervical explant culture. Antimicrob Agents Chemother 51: 1770-1779.
37. Cu-Uvin S, Hogan JW, Caliendo AM, Harwell J, Mayer KH & Carpenter CC (2001) Association between bacterial vaginosis and expression of human immunodeficiency virus type 1 RNA in the female genital tract. Clin Infect Dis 33: 894-896.
38. Damelin LH, Paximadis M, Mavri-Damelin D, Birkhead M, Lewis DA & Tiemessen CT (2011) Identification of predominant culturable vaginal Lactobacillus species and associated bacteriophages from women with and without vaginal discharge syndrome in South Africa. J Med Microbiol 60: 180-183.
39. de Man JC, Rogosa M & Sharpe ME (1960) A medium for the cultivation of lactobacilli. J Appl Bacteriol 23: 130-135.
40. de Witte L, Nabatov A, Pion M, Fluitsma D, de Jong MA, de GT, Piguet V, van KY & Geijtenbeek TB (2007) Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. Nat Med 13: 367-371.
41. Dei M, Di MF, Di PG & Bruni V (2010) Vulvovaginitis in childhood. Best Pract Res Clin Obstet Gynaecol 24: 129-137.
42. Dimitonova SP, Danova ST, Serkedjieva JP & Bakalov BV (2007) Antimicrobial activity and protective properties of vaginal lactobacilli from healthy Bulgarian women. Anaerobe 13: 178-184.
43. Dimitonova SP, Bakalov BV, Eksandrova-Georgieva RN & Danova ST (2008) Phenotypic and molecular identification of lactobacilli isolated from vaginal secretions. J Microbiol Immunol Infect 41: 469-477.
44. Döderlein A (1892) Das Scheidensekret und seine Bedeutung für das Puerperalfieber. Zentbl Bakteriol Microbiol Hyg Abt 11: 699.
45. Dominguez-Bello MG, Costello EK, Contreras M, Magris M, Hidalgo G, Fierer N & Knight R (2010) Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. P Natl Acad Sci USA 107: 11971-11975.
46. Donovan DM (2007) Bacteriophage and peptidoglycan degrading enzymes with antimicrobial applications. Recent Pat Biotechnol 1: 113-122.
47. Du Plessis EM & Dicks LM (1995) Evaluation of random amplified polymorphic DNA (RAPD)-PCR as a method to differentiate Lactobacillus acidophilus, Lactobacillus crispatus, Lactobacillus amylovorus, Lactobacillus gallinarum, Lactobacillus gasseri, and Lactobacillus johnsonii. Curr Microbiol 31: 114-118.
48. Duerkop BA, Vaishnava S & Hooper LV (2009) Immune responses to the microbiota at the intestinal mucosal surface. Immunity 31: 368-376.
49. Duh EJ, Maury WJ, Folks TM, Fauci AS & Rabson AB (1989) Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. P Natl Acad Sci USA 86: 5974-5978.
50. Ellis CL, Ma ZM, Mann SK et al. (2011) Molecular characterization of stool microbiota in HIV-infected subjects by panbacterial and order-level 16S ribosomal DNA (rDNA) quantification and correlations with immune activation. J Acquir Immune Defic Syndr 57: 363-370.
51. Falsen E, Pascual C, Sjoden B, Ohlen M & Collins MD (1999) Phenotypic and phylogenetic characterization of a novel Lactobacillus species from human sources: description of Lactobacillus iners sp. nov. Int J Syst Bacteriol 49(Pt 1): 217-221.
52. Fantuzzi L, Canini I, Belardelli F & Gessani S (2001) HIV-1 gp120 stimulates the production of beta-chemokines in human peripheral blood monocytes through a CD4-independent mechanism. J Immunol 166: 5381-5387.
53. Ferir G, Petrova MI, Andrei G et al. (2013) The lantibiotic peptide labyrinthopeptin A1 demonstrates broad anti-HIV and anti-HSV activity with potential for microbicidal applications. PLoS ONE 8: e64010.
54. Ferrari G, King K, Rathbun K, Place CA, Packard MV, Bartlett JA, Bolognesi DP & Weinhold KJ (1995) IL-7 enhancement of antigen-driven activation/expansion of HIV-1-specific cytotoxic T lymphocyte precursors (CTLp). Clin Exp Immunol 101: 239-248.
55. Fichorova RN, Yamamoto HS, Delaney ML, Onderdonk AB & Doncel GF (2011) Novel vaginal microflora colonization model providing new insight into microbicide mechanism of action. MBio 2: e00168-11.
56. Florey O, Kim SE, Sandoval CP, Haynes CM & Overholtzer M (2011) Autophagy machinery mediates macroendocytic processing and entotic cell death by targeting single membranes. Nat Cell Biol 13: 1335-1343.
57. Forsyth CB, Farhadi A, Jakate SM, Tang Y, Shaikh M & Keshavarzian A (2009) Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis. Alcohol 43: 163-172.
58. Fung KY, Mangan NE, Cumming H et al. (2013) Interferon-epsilon protects the female reproductive tract from viral and bacterial infection. Science 339: 1088-1092.
59. Gajer P, Brotman RM, Bai G et al. (2012) Temporal dynamics of the human vaginal microbiota. Sci Transl Med 4: 132ra52.
60. Gardiner GE, Heinemann C, Bruce AW, Beuerman D & Reid G (2002) Persistence of Lactobacillus fermentum RC-14 and Lactobacillus rhamnosus GR-1 but not L. rhamnosus GG in the human vagina as demonstrated by randomly amplified polymorphic DNA. Clin Diagn Lab Immunol 9: 92-96.
61. Garg KB, Ganguli I, Das R & Talwar GP (2009) Spectrum of Lactobacillus species present in healthy vagina of Indian women. Indian J Med Res 129: 652-657.
62. Geijtenbeek TB, Kwon DS, Torensma R et al. (2000) DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100: 587-597.
63. Ginhoux F, Tacke F, Angeli V, Bogunovic M, Loubeau M, Dai XM, Stanley ER, Randolph GJ & Merad M (2006) Langerhans cells arise from monocytes in vivo. Nat Immunol 7: 265-273.
64. Giomarelli B, Provvedi R, Meacci F, Maggi T, Medaglini D, Pozzi G, Mori T, McMahon JB, Gardella R & Boyd MR (2002) The microbicide cyanovirin-N expressed on the surface of commensal bacterium Streptococcus gordonii captures HIV-1. AIDS 16: 1351-1356.
65. Gipson IK, Ho SB, Spurr-Michaud SJ, Tisdale AS, Zhan Q, Torlakovic E, Pudney J, Anderson DJ, Toribara NW & Hill JA III (1997) Mucin genes expressed by human female reproductive tract epithelia. Biol Reprod 56: 999-1011.
66. Givan AL, White HD, Stern JE, Colby E, Gosselin EJ, Guyre PM & Wira CR (1997) Flow cytometric analysis of leukocytes in the human female reproductive tract: comparison of fallopian tube, uterus, cervix, and vagina. Am J Reprod Immunol 38: 350-359.
67. Gori A, Tincati C, Rizzardini G et al. (2008) Early impairment of gut function and gut flora supporting a role for alteration of gastrointestinal mucosa in human immunodeficiency virus pathogenesis. J Clin Microbiol 46: 757-758.
68. Gupta S, Kumar N, Singhal N, Kaur R & Manektala U (2006) Vaginal microflora in postmenopausal women on hormone replacement therapy. Indian J Pathol Microbiol 49: 457-461.
69. Handen JS & Rosenberg HF (1997) Suppression of HIV-1 transcription by beta-chemokines RANTES, MIP1-alpha, and MIP-1beta is not mediated by the NFAT-1 enhancer element. FEBS Lett 410: 301-302.
70. Harada H, Goto Y, Ohno T, Suzu S & Okada S (2007) Proliferative activation up-regulates expression of CD4 and HIV-1 co-receptors on NK cells and induces their infection with HIV-1. Eur J Immunol 37: 2148-2155.
71. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM & Weaver CT (2005) Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6: 1123-1132.
72. Hashemi FB, Ghassemi M, Roebuck KA & Spear GT (1999) Activation of human immunodeficiency virus type 1 expression by Gardnerella vaginalis. J Infect Dis 179: 924-930.
73. Hashemi FB, Ghassemi M, Faro S, Aroutcheva A & Spear GT (2000) Induction of human immunodeficiency virus type 1 expression by anaerobes associated with bacterial vaginosis. J Infect Dis 181: 1574-1580.
74. Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S, Lipford G, Wagner H & Bauer S (2004) Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303: 1526-1529.
75. Heinonen PK, Teisala K, Punnonen R, Miettinen A, Lehtinen M & Paavonen J (1985) Anatomic sites of upper genital tract infection. Obstet Gynecol 66: 384-390.
76. Hekmat S, Soltani H & Reid G (2008) Growth and survival of Lactobacillus reuteri RC-14 and Lactobacillus rhamnosus GR-1 in yogurt for use as a functional food. Innov Food Sci Emerg Technol 10: 293-296.
77. Hemsworth JC, Hekmat S & Reid G (2012) Micronutrient supplemented probiotic yogurt for HIV-infected adults taking HAART in London, Canada. Gut Microbes 3: 414-419.
78. Herbein G & Khan KA (2008) Is HIV infection a TNF receptor signalling-driven disease? Trends Immunol 29: 61-67.
79. Hickey DK, Patel MV, Fahey JV & Wira CR (2011) Innate and adaptive immunity at mucosal surfaces of the female reproductive tract: stratification and integration of immune protection against the transmission of sexually transmitted infections. J Reprod Immunol 88: 185-194.
80. Hill JA & Anderson DJ (1992) Human vaginal leukocytes and the effects of vaginal fluid on lymphocyte and macrophage defense functions. Am J Obstet Gynecol 166: 720-726.
81. Hill GB, St Claire KK & Gutman LT (1995) Anaerobes predominate among the vaginal microflora of prepubertal girls. Clin Infect Dis 20: S269-S270.
82. Hladik F & McElrath MJ (2008) Setting the stage: host invasion by HIV. Nat Rev Immunol 8: 447-457.
83. Hladik F, Sakchalathorn P, Ballweber L, Lentz G, Fialkow M, Eschenbach D & McElrath MJ (2007) Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. Immunity 26: 257-270.
84. Hooper LV, Littman DR & Macpherson AJ (2012) Interactions between the microbiota and the immune system. Science 336: 1268-1273.
85. Hougee S, Vriesema AJ, Wijering SC, Knippels LM, Folkerts G, Nijkamp FP, Knol J & Garssen J (2010) Oral treatment with probiotics reduces allergic symptoms in ovalbumin-sensitized mice: a bacterial strain comparative study. Int Arch Allergy Immunol 151: 107-117.
86. Hummelen R, Fernandes AD, Macklaim JM, Dickson RJ, Changalucha J, Gloor GB & Reid G (2010a) Deep sequencing of the vaginal microbiota of women with HIV. PLoS ONE 5: e12078.
87. Hummelen R, Vos AP, van't Land B, van Norren K & Reid G (2010b) Altered host-microbe interaction in HIV: a target for intervention with pro- and prebiotics. Int Rev Immunol 29: 485-513.
88. Hummelen R, Changalucha J, Butamanya NL, Koyama TE, Cook A, Habbema JD & Reid G (2011a) Effect of 25 weeks probiotic supplementation on immune function of HIV patients. Gut Microbes 2: 80-85.
89. Hummelen R, Macklaim JM, Bisanz JE, Hammond JA, McMillan A, Vongsa R, Koenig D, Gloor GB & Reid G (2011b) Vaginal microbiome and epithelial gene array in post-menopausal women with moderate to severe dryness. PLoS ONE 6: e26602.
90. Huskens D, Vermeire K, Vandemeulebroucke E, Balzarini J & Schols D (2008) Safety concerns for the potential use of cyanovirin-N as a microbicidal anti-HIV agent. Int J Biochem Cell Biol 40: 2802-2814.
91. Hussain LA & Lehner T (1995) Comparative investigation of Langerhans' cells and potential receptors for HIV in oral, genitourinary and rectal epithelia. Immunology 85: 475-484.
92. Irvine SL, Hummelen R, Hekmat S, Looman CW, Habbema JD & Reid G (2010) Probiotic yogurt consumption is associated with an increase of CD4 count among people living with HIV/AIDS. J Clin Gastroenterol 44: e201-e205.
93. Iwabuchi N, Takahashi N, Xiao JZ, Yonezawa S, Yaeshima T, Iwatsuki K & Hachimura S (2009) Suppressive effects of Bifidobacterium longum on the production of Th2-attracting chemokines induced with T cell-antigen-presenting cell interactions. FEMS Immunol Med Microbiol 55: 324-334.
94. Iwasaki A (2010) Antiviral immune responses in the genital tract: clues for vaccines. Nat Rev Immunol 10: 699-711.
95. Johnson-Henry KC, Donato KA, Shen-Tu G, Gordanpour M & Sherman PM (2008) Lactobacillus rhamnosus strain GG prevents enterohemorrhagic Escherichia coli O157:H7-induced changes in epithelial barrier function. Infect Immun 76: 1340-1348.
96. Kajikawa A, Zhang L, Long J, Nordone S, Stoeker L, LaVoy A, Bumgardner S, Klaenhammer T & Dean G (2012) Construction and immunological evaluation of dual cell surface display of HIV-1 gag and Salmonella enterica serovar Typhimurium FliC in Lactobacillus acidophilus for vaccine delivery. Clin Vaccine Immunol 19: 1374-1381.
97. Kalyoussef S, Nieves E, Dinerman E et al. (2012) Lactobacillus proteins are associated with the bactericidal activity against E. coli of female genital tract secretions. PLoS ONE 7: e49506.
98. Kane M, Case LK, Kopaskie K, Kozlova A, MacDearmid C, Chervonsky AV & Golovkina TV (2011) Successful transmission of a retrovirus depends on the commensal microbiota. Science 334: 245-249.
99. Karlsson M, Scherbak N, Reid G & Jass J (2012) Lactobacillus rhamnosus GR-1 enhances NF-kappaB activation in Escherichia coli-stimulated urinary bladder cells through TLR4. BMC Microbiol 12: 15.
100. Kelly P, Todd J, Sianongo S, Mwansa J, Sinsungwe H, Katubulushi M, Farthing MJ & Feldman RA (2009) Susceptibility to intestinal infection and diarrhoea in Zambian adults in relation to HIV status and CD4 count. BMC Gastroenterol 9: 7.
101. Kilic AO, Pavlova SI, Alpay S, Kilic SS & Tao L (2001) Comparative study of vaginal Lactobacillus phages isolated from women in the United States and Turkey: prevalence, morphology, host range, and DNA homology. Clin Diagn Lab Immunol 8: 31-39.
102. Klatt NR, Estes JD, Sun X et al. (2012) Loss of mucosal CD103+ DCs and IL-17+ and IL-22+ lymphocytes is associated with mucosal damage in SIV infection. Mucosal Immunol 5: 646-657.
103. Klebanoff SJ & Coombs RW (1991) Viricidal effect of Lactobacillus acidophilus on human immunodeficiency virus type 1: possible role in heterosexual transmission. J Exp Med 174: 289-292.
104. Kohler GA, Assefa S & Reid G (2010) Probiotic interference of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 with the opportunistic fungal pathogen Candida albicans. Infect Dis Obstet Gynecol 2010: 636474. DOI: 10.1155/2012/636474.
105. Konstantinov SR, Smidt H, de Vos WM et al. (2008) S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions. P Natl Acad Sci USA 105: 19474-19479.
106. Koren O, Knights D, Gonzalez A, Waldron L, Segata N, Knight R, Huttenhower C & Ley RE (2013) A guide to enterotypes across the human body: meta-analysis of microbial community structures in human microbiome datasets. PLoS Comput Biol 9: e1002863.
107. Lackner AA, Lederman MM & Rodriguez B (2012) HIV pathogenesis: the host. Cold Spring Harb Perspect Med 2: a007005.
108. Lagenaur LA, Sanders-Beer BE, Brichacek B, Pal R, Liu X, Liu Y, Yu R, Venzon D, Lee PP & Hamer DH (2011) Prevention of vaginal SHIV transmission in macaques by a live recombinant Lactobacillus. Mucosal Immunol 4: 648-657.
109. Lai SK, Hida K, Shukair S, Wang YY, Figueiredo A, Cone R, Hope TJ & Hanes J (2009) Human immunodeficiency virus type 1 is trapped by acidic but not by neutralized human cervicovaginal mucus. J Virol 83: 11196-11200.
110. Lamont RF, Sobel JD, Akins RA, Hassan SS, Chaiworapongsa T, Kusanovic JP & Romero R (2011) The vaginal microbiome: new information about genital tract flora using molecular based techniques. BJOG 118: 533-549.
111. Lebeer S, Vanderleyden J & De Keersmaecker SC (2010) Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nat Rev Microbiol 8: 171-184.
112. Lederman MM, Offord RE & Hartley O (2006) Microbicides and other topical strategies to prevent vaginal transmission of HIV. Nat Rev Immunol 6: 371-382.
113. Liu X, Lagenaur LA, Simpson DA et al. (2006) Engineered vaginal lactobacillus strain for mucosal delivery of the human immunodeficiency virus inhibitor cyanovirin-N. Antimicrob Agents Chemother 50: 3250-3259.
114. Liu JJ, Reid G, Jiang Y, Turner MS & Tsai CC (2007) Activity of HIV entry and fusion inhibitors expressed by the human vaginal colonizing probiotic Lactobacillus reuteri RC-14. Cell Microbiol 9: 120-130.
115. Liu X, Lagenaur LA, Lee PP & Xu Q (2008) Engineering of a human vaginal Lactobacillus strain for surface expression of two-domain CD4 molecules. Appl Environ Microbiol 74: 4626-4635.
116. Liu H, Gao Y, Yu LR, Jones RC, Elkins CA & Hart ME (2011) Inhibition of Staphylococcus aureus by lysostaphin-expressing Lactobacillus plantarum WCFS1 in a modified genital tract secretion medium. Appl Environ Microbiol 77: 8500-8508.
117. Luyer MD, Buurman WA, Hadfoune M, Speelmans G, Knol J, Jacobs JA, Dejong CH, Vriesema AJ & Greve JW (2005) Strain-specific effects of probiotics on gut barrier integrity following hemorrhagic shock. Infect Immun 73: 3686-3692.
118. Ma B, Forney LJ & Ravel J (2012) Vaginal microbiome: rethinking health and disease. Annu Rev Microbiol 66: 371-389.
119. Mac Bride MB, Rhodes DJ & Shuster LT (2010) Vulvovaginal atrophy. Mayo Clin Proc 85: 87-94.
120. MacDonald T (2008) The gut is still the biggest lymphoid organ in the body. Mucosal Immunol 1: 246-247.
121. Macklaim JM, Gloor GB, Anukam KC, Cribby S & Reid G (2011) At the crossroads of vaginal health and disease, the genome sequence of Lactobacillus iners AB-1. P Natl Acad Sci USA 108(suppl 1): 4688-4695.
122. Macklaim J, Fernandes AD, Di Bella JM, Hammond JA, Reid G & Gloor GB (2013) Comparative meta-RNA-seq of the vaginal microbiota and differential expression by Lactobacillus iners in health and dysbiosis. Microbiome 1: 12.
123. Maggi E, Mazzetti M, Ravina A et al. (1994) Ability of HIV to promote a TH1 to TH0 shift and to replicate preferentially in TH2 and TH0 cells. Science 265: 244-248.
124. Maher D, Wu X, Schacker T, Horbul J & Southern P (2005) HIV binding, penetration, and primary infection in human cervicovaginal tissue. P Natl Acad Sci USA 102: 11504-11509.
125. Malik S, Petrova MI, Claes IJ et al. (2013) The high auto-aggregative and adhesive phenotype of the vaginal Lactobacillus plantarum strain CMPG5300 is sortase-dependent. Appl Environ Microbiol 79: 4576-4585.
126. Mändar R (2013) Microbiota of male genital tract: Impact on the health of man and his partner. Pharmacol Res 69: 32-41.
127. Martin LS, McDougal JS & Loskoski SL (1985) Disinfection and inactivation of the human T lymphotropic virus type III/Lymphadenopathy-associated virus. J Infect Dis 152: 400-403.
128. Martin HL, Richardson BA, Nyange PM, Lavreys L, Hillier SL, Chohan B, Mandaliya K, Ndinya-Achola JO, Bwayo J & Kreiss J (1999) Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis 180: 1863-1868.
129. Martin R, Soberon N, Escobedo S & Suarez JE (2009) Bacteriophage induction versus vaginal homeostasis: role of H(2)O(2) in the selection of Lactobacillus defective prophages. Int Microbiol 12: 131-136.
130. Martinez RC, Franceschini SA, Patta MC, Quintana SM, Nunes AC, Moreira JL, Anukam KC, Reid G & De Martinis EC (2008) Analysis of vaginal lactobacilli from healthy and infected Brazilian women. Appl Environ Microbiol 74: 4539-4542.
131. Martinez MG, Prado AM, Candurra NA & Ruzal SM (2012) S-layer proteins of Lactobacillus acidophilus inhibits JUNV infection. Biochem Biophys Res Commun 422: 590-595.
132. Matu MN, Orinda GO, Njagi EN, Cohen CR & Bukusi EA (2010) In vitro inhibitory activity of human vaginal lactobacilli against pathogenic bacteria associated with bacterial vaginosis in Kenyan women. Anaerobe 16: 210-215.
133. McMillan A, Dell M, Zellar MP et al. (2011) Disruption of urogenital biofilms by lactobacilli. Colloids Surf B Biointerfaces 86: 58-64.
134. Mehandru S, Poles MA, Tenner-Racz K, Horowitz A, Hurley A, Hogan C, Boden D, Racz P & Markowitz M (2004) Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med 200: 761-770.
135. Meindl K, Schmiederer T, Schneider K et al. (2010) Labyrinthopeptins: a new class of carbacyclic lantibiotics. Angew Chem Int Ed Engl 49: 1151-1154.
136. Merlini E, Bai F, Bellistri GM, Tincati C, d'Arminio MA & Marchetti G (2011) Evidence for polymicrobic flora translocating in peripheral blood of HIV-infected patients with poor immune response to antiretroviral therapy. PLoS ONE 6: e18580.
137. Minkoff HL, Eisenberger-Matityahu D, Feldman J, Burk R & Clarke L (1999) Prevalence and incidence of gynecologic disorders among women infected with human immunodeficiency virus. Am J Obstet Gynecol 180: 824-836.
138. Mitchell C, Balkus JE, Fredricks D et al. (2012) Interaction between Lactobacilli, bacterial vaginosis-associated bacteria, and HIV type 1 RNA and DNA genital shedding in U.S. and Kenyan women. AIDS Res Hum Retroviruses 29: 13-19.
139. Mohamadzadeh M, Olson S, Kalina WV, Ruthel G, Demmin GL, Warfield KL, Bavari S & Klaenhammer TR (2005) Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. P Natl Acad Sci USA 102: 2880-2885.
140. Moran PA, Diegel ML, Sias JC, Ledbetter JA & Zarling JM (1993) Regulation of HIV production by blood mononuclear cells from HIV-infected donors: I. Lack of correlation between HIV-1 production and T cell activation. AIDS Res Hum Retroviruses 9: 455-464.
141. Mselle TF, Howell AL, Ghosh M, Wira CR & Sentman CL (2009) Human uterine natural killer cells but not blood natural killer cells inhibit human immunodeficiency virus type 1 infection by secretion of CXCL12. J Virol 83: 11188-11195.
142. Mueller YM, Do DH, Altork SR et al. (2008) IL-15 treatment during acute simian immunodeficiency virus (SIV) infection increases viral set point and accelerates disease progression despite the induction of stronger SIV-specific CD8+ T cell responses. J Immunol 180: 350-360.
143. Naik S, Bouladoux N, Wilhelm C et al. (2012) Compartmentalized control of skin immunity by resident commensals. Science 337: 1115-1119.
144. Narimatsu R, Wolday D & Patterson BK (2005) IL-8 increases transmission of HIV type 1 in cervical explant tissue. AIDS Res Hum Retroviruses 21: 228-233.
145. Nelson DE, Dong Q, Van der PB et al. (2012) Bacterial communities of the coronal sulcus and distal urethra of adolescent males. PLoS ONE 7: e36298.
146. Nikolic DS & Piguet V (2010) Vaccines and microbicides preventing HIV-1, HSV-2, and HPV mucosal transmission. J Invest Dermatol 130: 352-361.
147. Nugent RP, Krohn MA & Hillier SL (1991) Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 29: 297-301.
148. O'Connor TJ, Kinchington D, Kangro HO & Jeffries DJ (1995) The activity of candidate virucidal agents, low pH and genital secretions against HIV-1 in vitro. Int J STD AIDS 6: 267-272.
149. Ogawa Y, Kawamura T, Matsuzawa T et al. (2013) Antimicrobial peptide LL-37 produced by HSV-2-infected keratinocytes enhances HIV infection of langerhans cells. Cell Host Microbe 13: 77-86.
150. Ohlsson A & Shah VS (2013) Intrapartum antibiotics for known maternal Group B streptococcal colonization. Cochrane Database Syst Rev 1: CD007467.
151. Ohmit SE, Sobel JD, Schuman P, Duerr A, Mayer K, Rompalo A & Klein RS (2003) Longitudinal study of mucosal Candida species colonization and candidiasis among human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. J Infect Dis 188: 118-127.
152. Olivetta E, Percario Z, Fiorucci G et al. (2003) HIV-1 Nef induces the release of inflammatory factors from human monocyte/macrophages: involvement of Nef endocytotic signals and NF-kappa B activation. J Immunol 170: 1716-1727.
153. Olmsted SS, Khanna KV, Ng EM, Whitten ST, Johnson ON III, Markham RB, Cone RA & Moench TR (2005) Low pH immobilizes and kills human leukocytes and prevents transmission of cell-associated HIV in a mouse model. BMC Infect Dis 5: 79.
154. Ongradi J, Ceccherini-Nelli L, Pistello M, Specter S & Bendinelli M (1990) Acid sensitivity of cell-free and cell-associated HIV-1: clinical implications. AIDS Res Hum Retroviruses 6: 1433-1436.
155. Pessi T, Sutas Y, Hurme M & Isolauri E (2000) Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin Exp Allergy 30: 1804-1808.
156. Petrova MI, Mathys L, Lebeer S, Noppen S, Van Damme EJ, Tanaka H, Igarashi Y, Vaneechoutte M, Vanderleyden J & Balzarini J (2013) Inhibition of infection and transmission of HIV-1 and lack of significant impact on the vaginal commensal lactobacilli by carbohydrate-binding agents. J Antimicrob Chemother, DOI: 10.1093/jac/dkt152.
157. Pretzer G, Snel J, Molenaar D, Wiersma A, Bron PA, Lambert J, de Vos WM, van der MR, Smits MA & Kleerebezem M (2005) Biodiversity-based identification and functional characterization of the mannose-specific adhesin of Lactobacillus plantarum. J Bacteriol 187: 6128-6136.
158. Pudney J, Quayle AJ & Anderson DJ (2005) Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone. Biol Reprod 73: 1253-1263.
159. Pugliese A, Vidotto V, Beltramo T & Torre D (2005) Phagocytic activity in human immunodeficiency virus type 1 infection. Clin Diagn Lab Immunol 12: 889-895.
160. Pusch O, Boden D, Hannify S, Lee F, Tucker LD, Boyd MR, Wells JM & Ramratnam B (2005) Bioengineering lactic acid bacteria to secrete the HIV-1 virucide cyanovirin. J Acquir Immune Defic Syndr 40: 512-520.
161. Pusch O, Kalyanaraman R, Tucker LD, Wells JM, Ramratnam B & Boden D (2006) An anti-HIV microbicide engineered in commensal bacteria: secretion of HIV-1 fusion inhibitors by lactobacilli. AIDS 20: 1917-1922.
162. Rancinan C, Morlat P, Chene G et al. (1997) [Prevalence of clinical manifestations of allergic reactions in HIV infection. Cross sectional study of 115 subjects]. Rev Med Interne 18: 691-694.
163. Randelovic G, Mladenovic V, Ristic L, Otasevic S, Brankovic S, Mladenovic-Antic S, Bogdanovic M & Bogdanovic D (2012) Microbiological aspects of vulvovaginitis in prepubertal girls. Eur J Pediatr 171: 1203-1208.
164. Rao S, Hu S, McHugh L, Lueders K, Henry K, Zhao Q, Fekete RA, Kar S, Adhya S & Hamer DH (2005) Toward a live microbial microbicide for HIV: commensal bacteria secreting an HIV fusion inhibitor peptide. P Natl Acad Sci USA 102: 11993-11998.
165. Ravel J, Gajer P, Abdo Z et al. (2011) Vaginal microbiome of reproductive-age women. P Natl Acad Sci USA 108: 4680-4687.
166. Ravel J, Gajer P, Fu L, Mauck CK, Koenig SS, Sakamoto J, Motsinger-Reif AA, Doncel GF & Zeichner SL (2012) Twice-daily application of HIV microbicides alter the vaginal microbiota. MBio 3: e00370-12.
167. Rebbapragada A, Howe K, Wachihi C, Pettengell C, Sunderji S, Huibner S, Ball TB, Plummer FA, Jaoko W & Kaul R (2008) Bacterial vaginosis in HIV-infected women induces reversible alterations in the cervical immune environment. J Acquir Immune Defic Syndr 49: 520-522.
168. Reeves JD & Doms RW (2002) Human immunodeficiency virus type 2. J Gen Virol 83: 1253-1265.
169. Reid G (2008) Probiotic Lactobacilli for urogenital health in women. J Clin Gastroenterol 42: S234-S236.
170. Reid G (2010) The potential role for probiotic yogurt for people living with HIV/AIDS. Gut Microbes 1: 411-414.
171. Reid G, Cook RL & Bruce AW (1987) Examination of strains of lactobacilli for properties that may influence bacterial interference in the urinary tract. J Urol 138: 330-335.
172. Reid G, Millsap K & Bruce AW (1994) Implantation of Lactobacillus casei var rhamnosus into vagina. Lancet 344: 1229.
173. Reid G, Bruce AW, Fraser N, Heinemann C, Owen J & Henning B (2001) Oral probiotics can resolve urogenital infections. FEMS Immunol Med Microbiol 30: 49-52.
174. Reid G, Charbonneau D, Erb J, Kochanowski B, Beuerman D, Poehner R & Bruce AW (2003) Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol 35: 131-134.
175. Reid G, Younes JA, Van der Mei HC, Gloor GB, Knight R & Busscher HJ (2011) Microbiota restoration: natural and supplemented recovery of human microbial communities. Nat Rev Microbiol 9: 27-38.
176. Reuter MA, Pombo C & Betts MR (2012) Cytokine production and dysregulation in HIV pathogenesis: lessons for development of therapeutics and vaccines. Cytokine Growth Factor Rev 23: 181-191.
177. Reyes A, Haynes M, Hanson N, Angly FE, Heath AC, Rohwer F & Gordon JI (2010) Viruses in the faecal microbiota of monozygotic twins and their mothers. Nature 466: 334-338.
178. Rho M, Wu YW, Tang H, Doak TG & Ye Y (2012) Diverse CRISPRs evolving in human microbiomes. PLoS Genet 8: e1002441.
179. Robboy SJ & Bentley RC (2004) Histology for pathologists. 3rd edn, Stacey Mills, Wolters Kluwers Health, Lippincott Williams & Wilkins, Philadelphia.
180. Rodriguez JM, Collins MD, Sjoden B & Falsen E (1999) Characterization of a novel Atopobium isolate from the human vagina: description of Atopobium vaginae sp. nov. Int J Syst Bacteriol 49(Pt 4): 1573-1576.
181. Rose WA, McGowin CL, Spagnuolo RA, Eaves-Pyles TD, Popov VL & Pyles RB (2012) Commensal bacteria modulate innate immune responses of vaginal epithelial cell multilayer cultures. PLoS ONE 7: e32728.
182. Schaefer TM, Desouza K, Fahey JV, Beagley KW & Wira CR (2004) Toll-like receptor (TLR) expression and TLR-mediated cytokine/chemokine production by human uterine epithelial cells. Immunology 112: 428-436.
183. Schaefer TM, Fahey JV, Wright JA & Wira CR (2005) Innate immunity in the human female reproductive tract: antiviral response of uterine epithelial cells to the TLR3 agonist poly(I:C). J Immunol 174: 992-1002.
184. Schellenberg JJ & Plummer FA (2012) The microbiological context of HIV resistance: vaginal microbiota and mucosal inflammation at the viral point of entry. Int J Inflam 14: 131243.
185. Sewankambo N, Gray RH, Wawer MJ et al. (1997) HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet 350: 546-550.
186. Sha BE, Zariffard MR, Wang QJ, Chen HY, Bremer J, Cohen MH & Spear GT (2005) Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis. J Infect Dis 191: 25-32.
187. Shen R, Richter HE, Clements RH et al. (2009) Macrophages in vaginal but not intestinal mucosa are monocyte-like and permissive to human immunodeficiency virus type 1 infection. J Virol 83: 3258-3267.
188. Simoes JA, Hashemi FB, Aroutcheva AA, Heimler I, Spear GT, Shott S & Faro S (2001) Human immunodeficiency virus type 1 stimulatory activity by Gardnerella vaginalis: relationship to biotypes and other pathogenic characteristics. J Infect Dis 184: 22-27.
189. Song YL, Kato N, Matsumiya Y, Liu CX, Kato H & Watanabe K (1999) Identification of and hydrogen peroxide production by fecal and vaginal lactobacilli isolated from Japanese women and newborn infants. J Clin Microbiol 37: 3062-3064.
190. Spear GT, St JE & Zariffard MR (2007) Bacterial vaginosis and human immunodeficiency virus infection. AIDS Res Ther 4: 25.
191. Spear GT, Sikaroodi M, Zariffard MR, Landay AL, French AL & Gillevet PM (2008) Comparison of the diversity of the vaginal microbiota in HIV-infected and HIV-uninfected women with or without bacterial vaginosis. J Infect Dis 198: 1131-1140.
192. Spear GT, Gilbert D, Landay AL, Zariffard R, French AL, Patel P & Gillevet PM (2011) Pyrosequencing of the genital microbiotas of HIV-seropositive and -seronegative women reveals Lactobacillus iners as the predominant Lactobacillus species. Appl Environ Microbiol 77: 378-381.
193. Srinivasan S, Hoffman NG, Morgan MT et al. (2012) Bacterial communities in women with bacterial vaginosis: high resolution phylogenetic analyses reveal relationships of microbiota to clinical criteria. PLoS ONE 7: e37818.
194. St. John EP, Martinson J, Simoes JA, Landay AL & Spear GT (2007) Dendritic cell activation and maturation induced by mucosal fluid from women with bacterial vaginosis. Clin Immunol 125: 95-102.
195. St. John EP, Zariffard MR, Martinson JA, Simoes JA, Landay AL & Spear GT (2009) Effect of mucosal fluid from women with bacterial vaginosis on HIV trans-infection mediated by dendritic cells. Virology 385: 22-27.
196. Stoddard E, Ni H, Cannon G, Zhou C, Kallenbach N, Malamud D & Weissman D (2009) gp340 promotes transcytosis of human immunodeficiency virus type 1 in genital tract-derived cell lines and primary endocervical tissue. J Virol 83: 8596-8603.
197. Su Y, Zhang B & Su L (2013) CD4 detected from Lactobacillus helps understand the interaction between Lactobacillus and HIV. Microbiol Res 168: 273-277.
198. Sun J, Le GW, Shi YH & Su GW (2007) Factors involved in binding of Lactobacillus plantarum Lp6 to rat small intestinal mucus. Lett Appl Microbiol 44: 79-85.
199. Sun J, Zhou TT, Le GW & Shi YH (2010) Association of Lactobacillus acidophilus with mice Peyer's patches. Nutrition 26: 1008-1013.
200. Swingler S, Mann A, Jacque J et al. (1999) HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages. Nat Med 5: 997-1003.
201. Taha TE, Hoover DR, Dallabetta GA, Kumwenda NI, Mtimavalye LA, Yang LP, Liomba GN, Broadhead RL, Chiphangwi JD & Miotti PG (1998) Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS 12: 1699-1706.
202. Taha TE, Gray RH, Kumwenda NI, Hoover DR, Mtimavalye LA, Liomba GN, Chiphangwi JD, Dallabetta GA & Miotti PG (1999) HIV infection and disturbances of vaginal flora during pregnancy. J Acquir Immune Defic Syndr Hum Retrovirol 20: 52-59.
203. Thies FL, Konig W & Konig B (2007) Rapid characterization of the normal and disturbed vaginal microbiota by application of 16S rRNA gene terminal RFLP fingerprinting. J Med Microbiol 56: 755-761.
204. Thomas S (1928) Döderlein's Bacillus: Lactobacillus acidophilus. J Infect Dis 43: 218-227.
205. Vangelista L, Secchi M, Liu X, Bachi A, Jia L, Xu Q & Lusso P (2010) Engineering of Lactobacillus jensenii to secrete RANTES and a CCR5 antagonist analogue as live HIV-1 blockers. Antimicrob Agents Chemother 54: 2994-3001.
206. Vasquez A, Jakobsson T, Ahrne S, Forsum U & Molin G (2002) Vaginal lactobacillus flora of healthy Swedish women. J Clin Microbiol 40: 2746-2749.
207. Verhoeven V, Renard N, Makar A, Van RP, Bogers JP, Lardon F, Peeters M & Baay M (2013) Probiotics enhance the clearance of human papillomavirus-related cervical lesions: a prospective controlled pilot study. Eur J Cancer Prev 22: 46-51.
208. Vitali B, Pugliese C, Biagi E, Candela M, Turroni S, Bellen G, Donders GG & Brigidi P (2007) Dynamics of vaginal bacterial communities in women developing bacterial vaginosis, candidiasis, or no infection, analyzed by PCR-denaturing gradient gel electrophoresis and real-time PCR. Appl Environ Microbiol 73: 5731-5741.
209. Wagner RD & Johnson SJ (2012) Probiotic lactobacillus and estrogen effects on vaginal epithelial gene expression responses to Candida albicans. J Biomed Sci 19: 58.
210. Wenner M (2009) A cultured response to HIV. Nat Med 15: 594-597.
211. Wertz J, Isaacs-Cosgrove N, Holzman C & Marsh TL (2008) Temporal shifts in microbial communities in nonpregnant African-American women with and without bacterial vaginosis. Interdiscip Perspect Infect Dis 27: 181253.
212. WHO/FAO (2001) Evaluation of health and nutritional properties of powder milk and live lactic acid bacteria. Food and Agriculture Organization of the United Nations and World Health Organization Expert Consultation Report.
213. Willey JM & van der Donk WA (2007) Lantibiotics: peptides of diverse structure and function. Annu Rev Microbiol 61: 477-501.
214. Wink J, Kroppenstedt RM, Seibert G & Stackebrandt E (2003) Actinomadura namibiensis sp. nov. Int J Syst Evol Microbiol 53: 721-724.
215. Wira CR & Rossoll RM (2003) Oestradiol regulation of antigen presentation by uterine stromal cells: role of transforming growth factor-beta production by epithelial cells in mediating antigen-presenting cell function. Immunology 109: 398-406.
216. Wira CR, Fahey JV, Sentman CL, Pioli PA & Shen L (2005) Innate and adaptive immunity in female genital tract: cellular responses and interactions. Immunol Rev 206: 306-335.
217. Witkin SS, Linhares IM & Giraldo P (2007) Bacterial flora of the female genital tract: function and immune regulation. Best Pract Res Clin Obstet Gynaecol 21: 347-354.
218. Wu Z, Chen Z & Phillips DM (2003) Human genital epithelial cells capture cell-free human immunodeficiency virus type 1 and transmit the virus to CD4+ Cells: implications for mechanisms of sexual transmission. J Infect Dis 188: 1473-1482.
219. Yamamoto T, Zhou X, Williams CJ, Hochwalt A & Forney LJ (2009) Bacterial populations in the vaginas of healthy adolescent women. J Pediatr Adolesc Gynecol 22: 11-18.
220. Yeaman GR, Guyre PM, Fanger MW, Collins JE, White HD, Rathbun W, Orndorff KA, Gonzalez J, Stern JE & Wira CR (1997) Unique CD8+ T cell-rich lymphoid aggregates in human uterine endometrium. J Leukoc Biol 61: 427-435.
221. Yeaman GR, Collins JE, Fanger MW, Wira CR & Lydyard PM (2001) CD8+ T cells in human uterine endometrial lymphoid aggregates: evidence for accumulation of cells by trafficking. Immunology 102: 434-440.
222. Zarate G & Nader-Macias ME (2006) Influence of probiotic vaginal lactobacilli on in vitro adhesion of urogenital pathogens to vaginal epithelial cells. Lett Appl Microbiol 43: 174-180.
223. Zhou X, Bent SJ, Schneider MG, Davis CC, Islam MR & Forney LJ (2004) Characterization of vaginal microbial communities in adult healthy women using cultivation-independent methods. Microbiology 150: 2565-2573.
224. Zhou X, Brown CJ, Abdo Z, Davis CC, Hansmann MA, Joyce P, Foster JA & Forney LJ (2007) Differences in the composition of vaginal microbial communities found in healthy Caucasian and black women. ISME J 1: 121-133.